BSECompany Update2d ago · 5 Nov 2026, 11:45 am
As per attachment
GlaxoSmithKline Pharmaceuticals Ltd · 500660
✦ AI SummaryResults
GlaxoSmithKline Pharmaceuticals Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, showing a total income from operations of ₹2,987.34 crores and a net profit for the period of ₹1,516.25 crores.
Analysis Scores
Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Newspaper Publication